Abstract
Current renal transplantation guidelines at our institution require patients with high-grade carotid artery stenosis (CAS) (>80%) to either undergo carotid revascularization prior to listing or eliminate them as transplant candidates. The majority of these patients do not meet safety criteria to proceed with revascularization and are alternatively managed with optimal medical therapy. We sought to determine if maximal medical management offers benefit or protection from adverse events in patients with high-grade CAS and end-stage renal disease (ESRD).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
